Patents Assigned to Copenhagen University
  • Patent number: 11376230
    Abstract: The present invention pertains to use of sodium diacetate (NaHAc2) as an antimicrobial agent against bacteria growing in biofilms. The aspects of the invention include a wound care product comprising sodium diacetate, a kit comprising a wound care product, and a method of treating an infected wound.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: July 5, 2022
    Assignees: Rigshospitalet Copenhagen University Hospital, Bispebjerg Hospital
    Inventors: Thomas Bjarnsholt, Klaus Kirketerp-Moller, Michael Christian Givskov
  • Publication number: 20210230633
    Abstract: The present invention relates to a vaccine comprising a nucleic acid construct such as a DNA construct especially a nucleic acid construct comprising sequences encoding invariant chain operatively linked to antigenic protein or peptide encoding sequences. The vaccine stimulates an immune response, especially an immune response in an MHC-I dependent, but CD4+ T-cell independent manner.
    Type: Application
    Filed: February 3, 2021
    Publication date: July 29, 2021
    Applicant: Copenhagen University
    Inventors: Peter Johannes Holst, Allan Randrup Thomsen, Jan Pravsgaard Christensen
  • Patent number: 10246513
    Abstract: The present invention relates to antagonists or inhibitors, which bind selectively to RANKL/OPGbp and regulate the interaction between RANKL/OPGbp and RANK/OPG. In particular, the present invention relates to an antibody or antigen binding domain, fragment or derivative thereof, immunoreactive with a RANKL/OPGbppeptide for use in the treatment, prevention or alleviation of male infertility or reduced male fertility such as oligospermia or azospermia.
    Type: Grant
    Filed: August 4, 2014
    Date of Patent: April 2, 2019
    Assignee: RIGSHOSPITALET COPENHAGEN UNIVERSITY HOSPITAL
    Inventor: Martin Blomberg Jensen
  • Patent number: 9655840
    Abstract: The present invention relates to wound care products, devices and methods incorporating acetic acid for the treatment of bacterial infections, in particular bacterial biofilm infections. In particular it relates to a wound care product comprising acetic acid, wherein the product comprises at least one further antibacterial compound; a delivery system comprising a container connected to a means of delivery which is connected to a pad, wherein said container comprises a composition comprising acetic acid and said pad comprises a self-adhesive material; a kit comprising a dressing and an adhesive membrane, wherein the dressing comprises a composition comprising acetic acid; a method of treating a wound comprising a) applying acetic acid to the wound and b) applying a negative pressure to the wound.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: May 23, 2017
    Assignees: RIGSHOSPITALET, COPENHAGEN UNIVERSITY HOSPITAL, BISPEBJERG HOSPITAL
    Inventors: Michael Christian Givskov, Thomas Bjarnsholt, Klaus Kirketerp-Møller
  • Publication number: 20150368672
    Abstract: The present invention relates to a vaccine comprising a nucleic acid construct such as a DNA construct especially a nucleic acid construct comprising sequences encoding invariant chain operatively linked to antigenic protein or peptide encoding sequences. The vaccine stimulates an immune response, especially an immune response in an MHC-I dependent, but CD4+ T-cell independent manner.
    Type: Application
    Filed: August 4, 2015
    Publication date: December 24, 2015
    Applicant: Copenhagen University
    Inventors: Peter Johannes Holst, Allan Randrup Thomsen, Jan Pravsgaard Christensen
  • Publication number: 20140272998
    Abstract: The present invention relates to the field of cancer-diagnostics. In particular the invention relates to a microRNA expression signature that allows discriminating skin samples of cutaneous T-cell lymphomas (CTCL) from non-malignant (inflammantory) skin samples by use of quantitative polymerase chain reaction performed on reverse transcribed miRNA. miR-155, miR-326, miR-663b, miR-203 and miR-205 are shown to be differentially expressed.
    Type: Application
    Filed: July 13, 2012
    Publication date: September 18, 2014
    Applicants: LEO PHARMA A/S, COPENHAGEN UNIVERSITY, RIGSHOSPITALET, GENTOFTE HOSPITAL
    Inventors: Ulrik Ralfkiaer, Peter Hagedorn, Charlotte Busch Ahler, Carsten Geisler, Anders Woetmann, Lone Skov, Niels Feentved Odum, Elisabeth Ralfkiaer
  • Publication number: 20140100419
    Abstract: The present invention relates to methods for improving the ability of spermatozoa to fertilize an egg in vitro and/or vivo, said method comprising providing a medium comprising active vitamin D (calcitriol) or analogs thereof, providing a sample of spermatozoa, and incubating said sample of spermatozoa with said medium. In addition, the invention relates to compositions comprising active vitamin D or analogs thereof for use in the treatment of infertility in a male or female subject.
    Type: Application
    Filed: January 31, 2012
    Publication date: April 10, 2014
    Applicant: RIGSHOSPITALET COPENHAGEN UNIVERSITY HOSPITAL
    Inventor: Martin Blomberg Jensen
  • Publication number: 20140046276
    Abstract: The present invention pertains to use of sodium diacetate (NaHAc2) as an antimicrobial agent against bacteria growing in biofilms. The aspects of the invention include a wound care product comprising sodium diacetate, a kit comprising a wound care product, and a method of treating an infected wound.
    Type: Application
    Filed: April 18, 2012
    Publication date: February 13, 2014
    Applicants: RIGSHOSPITALET COPENHAGEN UNIVERSITY HOSPITAL, BISPEBJERG HOSPITAL, DANMARKS TEKNISKE UNIVERSITET
    Inventors: Thomas Bjarnsholt, Klaus Kirketerp-Moller, Michael Christian Givskov
  • Publication number: 20130060208
    Abstract: The present invention relates to wound care products, devices and methods incorporating acetic acid for the treatment of bacterial infections, in particular bacterial biofilm infections. In particular it relates to a wound care product comprising acetic acid, wherein the product comprises at least one further antibacterial compound; a delivery system comprising a container connected to a means of delivery which is connected to a pad, wherein said container comprises a composition comprising acetic acid and said pad comprises a self-adhesive material; a kit comprising a dressing and an adhesive membrane, wherein the dressing comprises a composition comprising acetic acid; a method of treating a wound comprising a) applying acetic acid to the wound and b) applying a negative pressure to the wound.
    Type: Application
    Filed: December 21, 2010
    Publication date: March 7, 2013
    Applicants: RIGSHOSPITALET, COPENHAGEN UNIVERSITY HOSPITAL, BISPEBJERG HOSPITAL, DANMARKS TEKNISKE UNIVERSITET
    Inventors: Michael Christian Givskov, Thomas Bjarnsholt, Klaus Kirketerp-Møller
  • Publication number: 20130045890
    Abstract: The present invention relates generally to a method for predicting the fertility potential in a male mammal. In particular it relates to a method for predicting the fertility potential in a male mammal by determining the expression of at least one protein of the vitamin D metabolising machinery in a semen sample. The expression level of the at least one protein of the vitamin D metabolising machinery is then indicative of the fertility potential of the subject. An object of the present invention relates to a method, which can predict whether the semen quality is sufficient to achieve pregnancy spontaneously or if the couple should proceed to assisted reproduction or further investigation.
    Type: Application
    Filed: May 3, 2011
    Publication date: February 21, 2013
    Applicant: Rigshospitalet Copenhagen University Hospital
    Inventors: Martin Blomberg Jensen, John Erik Nielsen, Niels Jorgensen, Kristian Almstrup, Henrik Leffers
  • Patent number: 8138148
    Abstract: The present invention relates to peptide fragments derived from the proteins belonging to the TGFbeta superfamily, pharmaceutical compositions comprising these peptide fragments and uses thereof for treatment of a disease or condition wherein the effects of stimulating neuronal cell differentiation, neuronal cell survival, stimulating neural plasticity associated with learning and memory and/or inhibiting inflammatory response are beneficial for treatment.
    Type: Grant
    Filed: August 15, 2006
    Date of Patent: March 20, 2012
    Assignee: Copenhagen University
    Inventors: Elisabeth Bock, Vladimir Berezin
  • Patent number: 8008259
    Abstract: The present invention relates to peptide sequences capable of stimulating neuronal cell differentiation, neural cell survival and neuronal plasticity associated with memory and learning. The peptide sequences of the invention are derived from the proteins belonging to neurotrophic factors, such as NGF, NT3, NT4/5 and BDNF. The invention also relates to pharmaceutical compositions comprising said peptide fragments and uses thereof for treatment of a disease or condition wherein the effects of stimulating neuronal cell differentiation, neuronal cell survival, stimulating neural plasticity associated with learning and memory are beneficial for treatment.
    Type: Grant
    Filed: November 7, 2006
    Date of Patent: August 30, 2011
    Assignee: Copenhagen University, Techtrans Unit
    Inventors: Elisabeth Bock, Vladimir Berezin
  • Publication number: 20100278904
    Abstract: The present invention relates to a vaccine comprising a nucleic acid construct such as a DNA construct especially a nucleic acid construct comprising sequences encoding invariant chain operatively linked to antigenic protein or peptide encoding sequences. The vaccine stimulates an immune response, especially an immune response in an MHC-I dependent, but CD4+ T-cell independent manner.
    Type: Application
    Filed: November 30, 2006
    Publication date: November 4, 2010
    Applicant: Copenhagen University
    Inventors: Peter Johannes Holst, Allan Randrup Thomsen, Jan Pravsgaard Christensen
  • Publication number: 20090221506
    Abstract: The present invention relates to peptide fragments derived from the proteins belonging to the TGFbeta superfamily, pharmaceutical compositions comprising said peptide fragments and uses thereof for treatment of a disease or condition wherein the effects of stimulating neuronal cell differentiation, neuronal cell survival, stimulating neural plasticity associated with learning and memory and/or inhibiting inflammatory response are beneficial for treatment.
    Type: Application
    Filed: August 15, 2006
    Publication date: September 3, 2009
    Applicant: Copenhagen University
    Inventors: Elisabeth Bock, Vladimir Berezin
  • Publication number: 20090074779
    Abstract: The present invention relates to peptide sequences capable of stimulating neuronal cell differentiation, neural cell survival and neuronal plasticity associated with memory and learning. The peptide sequences of the invention are derived from the proteins belonging to neurotrophic factors, such as NGF, NT3, NT4/5 and BDNF. The invention also relates to pharmaceutical compositions comprising said peptide fragments and uses thereof for treatment of a disease or condition wherein the effects of stimulating neuronal cell differentiation, neuronal cell survival, stimulating neural plasticity associated with learning and memory are beneficial for treatment.
    Type: Application
    Filed: November 7, 2006
    Publication date: March 19, 2009
    Applicant: Copenhagen University
    Inventors: Elisabeth Bock, Vladimir Berezin